v3 Template
N

Nyxoah S.A.

Medical Technology New York, USA ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$530.5M
Funding Rounds
13
Last Funding
2026-06-30

About Nyxoah S.A.

Nyxoah is a medical technology company focused on developing and commercializing innovative solutions for treating Obstructive Sleep Apnea (OSA). Their lead solution, Genio®, offers an alternative to CPAP therapy through hypoglossal nerve stimulation, targeting patients with moderate to severe OSA who cannot tolerate or have refused CPAP therapy.

Products & Services

Genio®:An alternative treatment for moderate to severe Obstructive Sleep Apnea (OSA) using hypoglossal nerve stimulation, designed for patients who cannot tolerate, have failed, or refused CPAP therapy.
Genio® system

Specialties

Obstructive Sleep Apnea (OSA) Treatment Hypoglossal Nerve Stimulation hypoglossal neurostimulation therapy Obstructive Sleep Apnea treatment hypoglossal neurostimulation therapy for OSA treatment of obstructive sleep apnea

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Financing
T: -
FT: Financing 		A: 110000000
MR: -
FA: $110M
FAN: 110000000 		D: 2026-06-30
FD: 2026-06-30 		-
2 RT: Debt
T: -
FT: Debt 		A: 15000000
MR: -
FA: $15 million
FAN: 15000000 		D: 2026-06-17
FD: 2026-06-17 		1 investors
3 RT: Equity and Debt
T: -
FT: Equity and Debt 		A: 110000000
MR: -
FA: $110 Million
FAN: 110000000 		D: 2026-06-10
FD: 2026-06-10 		2 investors
4 RT: Convertible Bonds
T: -
FT: Convertible Bonds 		A: 24750000
MR: -
FA: €22.5 million
FAN: 24750000 		D: 2025-12-19
FD: 2025-12-19 		1 investors
5 RT: Equity and Convertible Bond
T: -
FT: Equity and Convertible Bond 		A: 77000000
MR: -
FA: up to U.S. $77 million
FAN: 77000000 		D: 2025-11-13
FD: 2025-11-13 		8 investors
6 RT: ATM Offering
T: -
FT: ATM Offering 		A: 27000000
MR: -
FA: $27 million
FAN: 27000000 		D: 2024-10-07
FD: 2024-10-07 		1 investors
7 RT: Debt
T: -
FT: Debt 		A: 40500000
MR: -
FA: €37.5 Million
FAN: 40500000 		D: 2024-07-03
FD: 2024-07-03 		1 investors
8 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering 		A: 52500000
MR: -
FA: approximately $52.5 million
FAN: 52500000 		D: 2024-05-31
FD: 2024-05-31 		2 investors
9 RT: Underwritten Public Offering
T: -
FT: Underwritten Public Offering 		A: 50000000
MR: -
FA: approximately $50 million
FAN: 50000000 		D: 2024-05-23
FD: 2024-05-23 		2 investors
10 RT: At-the-Market Equity Offering
T: -
FT: At-the-Market Equity Offering 		A: 3000000
MR: -
FA: $3.0 million
FAN: 3000000 		D: 2023-04-13
FD: 2023-04-13 		-
11 RT: ATM Equity Offering
T: -
FT: ATM Equity Offering 		A: 3000000
MR: -
FA: 3.0 million
FAN: 3000000 		D: 2023-04-13
FD: 2023-04-13 		1 investors
12 RT: At-the-Market Equity Offering
T: -
FT: At-the-Market Equity Offering 		A: 2800000
MR: -
FA: $2.8 million
FAN: 2800000 		D: 2023-03-27
FD: 2023-03-27 		1 investors
13 RT: Private Placement
T: -
FT: Private Placement 		A: 15000000
MR: -
FA: €13.35 million
FAN: 15000000 		D: 2023-03-23
FD: 2023-03-23 		3 investors
Financing Latest
2026-06-30
$110.0M
Debt 2026-06-17
$15.0M
Equity and Debt 2026-06-10
$110.0M

View 12 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Robert Taub

Founder and Chairman

K

Kevin Rakin

Independent Director

J

Jürgen Hambrecht

Independent Director

R

Rita Johnson-Mills

Independent Director

V

Virginia Kirby

Independent Director

D

Daniel Wildman

Independent Director

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Nyxoah S.A. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
nyxoah.com
Industries
Medical Technology
Company Size
~360 employees (est.)
Locations
New York, USA
Los Angeles, USA
New York, United States +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro